Literature DB >> 27170392

Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis.

Guadalupe Garcia-Tsao1.   

Abstract

Cirrhosis is not a single entity but represents a disease progression across different prognostic stages, with the compensated and decompensated stages being the most important. Variceal hemorrhage (VH) and ascites are complications of cirrhosis that denote the presence of a decompensated stage. Spontaneous bacterial peritonitis (SBP) is a common bacterial infection unique to patients with cirrhosis that can precipitate the development of recurrent VH and hepatorenal syndrome (HRS), complications that denote the presence of a 'further decompensated' stage of cirrhosis. Main current issues in the management of VH include identification of different prognostic stages that allow for individualized patient care. Management of VH cannot be performed in an isolated manner, and the presence of other complications of cirrhosis (ascites, encephalopathy) should be taken into account both in the management and in the design of clinical trials. Because management of ascites per se has not resulted in significant changes in mortality, main management issues consist of preventing further decompensating events by preventing factors that will lead to worsening vasodilatation and hemodynamic status (infections, vasodilators), preventing volume depletion (overdiuresis, GI hemorrhage) and preventing structural kidney injury (nephrotoxins). Prophylaxis of bacterial infections such as SBP currently consists of the administration of antibiotics. By preventing infections, there is evidence that recurrent VH and HRS can also be prevented. However, response to recommended empirical antibiotics in patients with suspected infection, such as SBP, is currently significantly lower than in the past because of an increase in infections secondary to multidrug resistant (MDR) organisms. One of the main predictors of the development of MDR organisms is antibiotic prophylaxis and unnecessary and prolonged use of antibiotics in hospital. Therefore, appropriate antibiotics should be used in patients with a high suspicion of infection, and antibiotic prophylaxis should be restricted to patients with the highest risk of infection.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27170392     DOI: 10.1159/000444551

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  18 in total

1.  Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studies.

Authors:  Ejaz Cheema; Aliaa Al-Aryan; Abdullah Al-Hamid
Journal:  Eur J Clin Pharmacol       Date:  2019-05-11       Impact factor: 2.953

2.  Low potassium disrupt intestinal barrier and result in bacterial translocation.

Authors:  Haishan Wu; Rong Huang; Jinjin Fan; Ning Luo; Xiao Yang
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

3.  Spontaneous Bacterial Peritonitis: The Incremental Value of a Fast and Direct Bacterial Identification from Ascitic Fluids Inoculated in Blood Culture Bottles by MALDI-TOF MS for a Better Management of Patients.

Authors:  Romain Lotte; Audrey Courdurié; Alice Gaudart; Audrey Emery; Alicia Chevalier; Albert Tran; Mathilde Payen; Raymond Ruimy
Journal:  Microorganisms       Date:  2022-06-09

4.  Systemic review and network meta-analysis: Prophylactic antibiotic therapy for spontaneous bacterial peritonitis.

Authors:  Nolan Faust; Akihiro Yamada; Haider Haider; Yuga Komaki; Fukiko Komaki; Dejan Micic; Atsushi Sakuraba
Journal:  World J Hepatol       Date:  2020-05-27

Review 5.  Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy.

Authors:  Murad Feroz Bandali; Anirudh Mirakhur; Edward Wolfgang Lee; Mollie Clarke Ferris; David James Sadler; Robin Ritchie Gray; Jason Kam Wong
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

6.  Can the Computed Tomographic Aspect of Porto-Systemic Circulation in Cirrhotic Patients be Associated with the Presence of Variceal Hemorrhage?

Authors:  Cosmin Caraiani; Bianca Petresc; Anamaria Pop; Magda Rotaru; Lidia Ciobanu; Horia Ștefănescu
Journal:  Medicina (Kaunas)       Date:  2020-06-19       Impact factor: 2.430

7.  Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms.

Authors:  Philip G Ferstl; Mona Müller; Natalie Filmann; Michael Hogardt; Volkhard Aj Kempf; Thomas A Wichelhaus; Christian M Lange; Johannes Vermehren; Stefan Zeuzem; Claudia Reinheimer; Oliver Waidmann
Journal:  Infect Drug Resist       Date:  2018-11-02       Impact factor: 4.003

8.  Portal Venous Flow Is Increased by Jejunal but Not Colonic Hydrogen Sulfide in a Nitric Oxide-Dependent Fashion in Rats.

Authors:  Aleksandr Birg; Henry C Lin; Nancy Kanagy
Journal:  Dig Dis Sci       Date:  2020-09-11       Impact factor: 3.487

9.  Patient Response to Endoscopic Therapy for Gastroesophageal Varices Based on Endoscopic Ultrasound Findings.

Authors:  Yujen Tseng; Lili Ma; Tiancheng Luo; Xiaoqing Zeng; Feng Li; Na Li; Yichao Wei; Shiyao Chen
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

10.  Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Authors:  Dengke Teng; Hao Zuo; Lin Liu; Jinghui Dong; Lei Ding
Journal:  Virol J       Date:  2018-10-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.